A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy Volunteers
Status:
Completed
Trial end date:
2018-11-09
Target enrollment:
Participant gender:
Summary
This study was a non-randomized, open-label, one-sequence, two-period within-subject study to
investigate the effect of CYP3A inhibition on the PK of balovaptan in healthy male and female
volunteers using itraconazole as a CYP3A inhibitor. The study was conducted at 1 site in the
Netherlands.